Posted in Regulatory Novo Nordisk preps filings for sickle cell drug etavopivat April 21, 2026 Pharmaphorum Novo Nordisk has claimed a key win in its head-to-head race with Agios to bring an oral PKR activator to the market for sickle cell disease. RegulatoryHematologyRead full story